Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Debt Ratio (2016 - 2025)

Haemonetics has reported Debt Ratio over the past 16 years, most recently at 0.49 for Q4 2025.

  • For Q4 2025, Debt Ratio rose 1.61% year-over-year to 0.49; the TTM value through Dec 2025 reached 0.49, up 1.61%, while the annual FY2025 figure was 0.5, 35.82% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.49 at Haemonetics, down from 0.5 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.5 in Q3 2025 and troughed at 0.37 in Q1 2024.
  • A 5-year average of 0.44 and a median of 0.43 in 2022 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: surged 80.57% in 2022 and later fell 13.56% in 2023.
  • Year by year, Debt Ratio stood at 0.43 in 2021, then fell by 5.8% to 0.41 in 2022, then dropped by 3.09% to 0.4 in 2023, then rose by 22.3% to 0.48 in 2024, then increased by 1.61% to 0.49 in 2025.
  • Business Quant data shows Debt Ratio for HAE at 0.49 in Q4 2025, 0.5 in Q3 2025, and 0.5 in Q2 2025.